Total Payments
$771,286
2023 Payments
$26,250
Companies
7
Transactions
110
Payment Breakdown by Category
Consulting$770,786 (99.9%)
Other$500.00 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $770,786 | 109 | 99.9% |
| Honoraria | $500.00 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Progenics Pharmaceuticals, Inc. | $462,869 | 49 | $0 (2023) |
| Vertex Pharmaceuticals Incorporated | $114,368 | 20 | $0 (2018) |
| US WorldMeds, LLC | $93,250 | 30 | $0 (2020) |
| Valeant Pharmaceuticals North America LLC | $42,075 | 3 | $0 (2017) |
| Amneal Pharmaceuticals LLC | $39,375 | 6 | $0 (2017) |
| Sprout Pharmaceuticals, Inc. | $14,350 | 1 | $0 (2018) |
| Eisai Inc. | $5,000 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $26,250 | 2 | Progenics Pharmaceuticals, Inc. ($26,250) |
| 2022 | $134,575 | 11 | Progenics Pharmaceuticals, Inc. ($134,575) |
| 2021 | $149,050 | 15 | Progenics Pharmaceuticals, Inc. ($149,050) |
| 2020 | $67,781 | 20 | Progenics Pharmaceuticals, Inc. ($50,131) |
| 2019 | $102,863 | 11 | Progenics Pharmaceuticals, Inc. ($102,863) |
| 2018 | $109,330 | 27 | US WorldMeds, LLC ($75,600) |
| 2017 | $181,438 | 24 | VERTEX PHARMACEUTICALS INCORPORATED ($94,988) |
All Payment Transactions
110 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/27/2023 | Progenics Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $10,500.00 | General |
| 04/13/2023 | Progenics Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $15,750.00 | General |
| 12/29/2022 | Progenics Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $9,975.00 | General |
| 11/17/2022 | Progenics Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $16,012.50 | General |
| 10/06/2022 | Progenics Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $10,237.50 | General |
| 09/15/2022 | Progenics Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $10,500.00 | General |
| 08/11/2022 | Progenics Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $17,587.50 | General |
| 07/07/2022 | Progenics Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $13,912.50 | General |
| 06/09/2022 | Progenics Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $10,500.00 | General |
| 05/12/2022 | Progenics Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $14,262.50 | General |
| 04/07/2022 | Progenics Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $11,900.00 | General |
| 03/03/2022 | Progenics Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $9,887.50 | General |
| 01/06/2022 | Progenics Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $9,800.00 | General |
| 12/02/2021 | Progenics Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $22,575.00 | General |
| 11/04/2021 | Progenics Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $8,137.50 | General |
| 10/07/2021 | Progenics Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $11,287.50 | General |
| 09/09/2021 | Progenics Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $16,625.00 | General |
| 07/29/2021 | Progenics Pharmaceuticals, Inc. | AZEDRA (Drug) | Consulting Fee | Cash or cash equivalent | $10,937.50 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 07/29/2021 | Progenics Pharmaceuticals, Inc. | AZEDRA (Drug) | Consulting Fee | Cash or cash equivalent | $1,487.50 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 07/08/2021 | Progenics Pharmaceuticals, Inc. | PYLARIFY (Drug) | Consulting Fee | Cash or cash equivalent | $15,050.00 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 07/08/2021 | Progenics Pharmaceuticals, Inc. | PYLARIFY (Drug) | Consulting Fee | Cash or cash equivalent | $525.00 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 07/08/2021 | Progenics Pharmaceuticals, Inc. | PYLARIFY (Drug) | Consulting Fee | Cash or cash equivalent | $350.00 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 07/01/2021 | Progenics Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $12,250.00 | General |
| 06/24/2021 | Progenics Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $20,825.00 | General |
| 05/06/2021 | Progenics Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $9,012.50 | General |
About Dr. Stuart Apfel, MD
Dr. Stuart Apfel, MD is a Neurology healthcare provider based in West Hempstead, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/25/2008. The National Provider Identifier (NPI) number assigned to this provider is 1538316252.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stuart Apfel, MD has received a total of $771,286 in payments from pharmaceutical and medical device companies, with $26,250 received in 2023. These payments were reported across 110 transactions from 7 companies. The most common payment nature is "Consulting Fee" ($770,786).
Ad
Practice Information
- Specialty Neurology
- Location West Hempstead, NY
- Active Since 08/25/2008
- Last Updated 08/25/2008
- Taxonomy Code 2084N0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1538316252
Products in Payments
- KALYDECO (Drug) $114,368
- MYOBLOC (Biological) $75,600
- AZEDRA (Drug) $64,100
- ADDYI (Drug) $42,075
- Tigecycline (73 H) (Drug) $25,550
- APOKYN (Drug) $17,150
- PYLARIFY (Drug) $15,925
- Halaven (Drug) $5,000
- Salsalate (12.25 H) (Drug) $4,288
- Doxycycline (8.25 H) (Drug) $2,888
- Phenazopyridine (8.25 H) (Drug) $2,888
- phenobarbital hyoscyamine atropine scopolamine (8.25 H) (Drug) $2,888
- Phosphenytoin (HHE) (Drug) $875.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.